Medipharm Labs Corp Stock Fundamentals
| MEDIF Stock | USD 0.05 0 2.22% |
Medipharm Labs Corp fundamentals help investors to digest information that contributes to Medipharm Labs' financial success or failures. It also enables traders to predict the movement of Medipharm OTC Stock. The fundamental analysis module provides a way to measure Medipharm Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medipharm Labs otc stock.
Medipharm |
Medipharm Labs Corp OTC Stock Return On Asset Analysis
Medipharm Labs' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medipharm Labs Return On Asset | -0.24 |
Most of Medipharm Labs' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medipharm Labs Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medipharm Labs Corp has a Return On Asset of -0.236. This is 97.3% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 68.57% higher than that of the company.
Medipharm Labs Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medipharm Labs's current stock value. Our valuation model uses many indicators to compare Medipharm Labs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medipharm Labs competition to find correlations between indicators driving Medipharm Labs's intrinsic value. More Info.Medipharm Labs Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medipharm Labs' earnings, one of the primary drivers of an investment's value.Medipharm Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medipharm Labs' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medipharm Labs could also be used in its relative valuation, which is a method of valuing Medipharm Labs by comparing valuation metrics of similar companies.Medipharm Labs is currently under evaluation in return on asset category among its peers.
Medipharm Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.24 | |||
| Profit Margin | (2.07) % | |||
| Operating Margin | (1.61) % | |||
| Current Valuation | 3.05 M | |||
| Shares Outstanding | 280.51 M | |||
| Shares Owned By Insiders | 3.92 % | |||
| Shares Owned By Institutions | 7.05 % | |||
| Price To Book | 0.36 X | |||
| Price To Sales | 0.69 X | |||
| Revenue | 21.71 M | |||
| Gross Profit | (13.42 M) | |||
| EBITDA | (38.55 M) | |||
| Net Income | (54.8 M) | |||
| Cash And Equivalents | 21.99 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 1.44 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 5.23 X | |||
| Book Value Per Share | 0.22 X | |||
| Cash Flow From Operations | (13.21 M) | |||
| Earnings Per Share | (0.14) X | |||
| Number Of Employees | 190 | |||
| Beta | 1.15 | |||
| Market Capitalization | 16.26 M | |||
| Total Asset | 92.36 M | |||
| Z Score | 6.6 | |||
| Net Asset | 92.36 M |
About Medipharm Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medipharm Labs Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medipharm Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medipharm Labs Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. MEDIPHARM LABS is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Medipharm OTC Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.